Zacks Investment ResearchThu, 26 Mar 2026 16:32:13 GMTTransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound?TMDX+4.27%
Zacks Investment ResearchWed, 25 Mar 2026 15:36:09 GMTReasons to Retain TransMedics Stock in Your Portfolio for NowTMDX+4.27%
Seeking AlphaMon, 09 Mar 2026 14:20:42 GMTTransMedics: Numb Reaction To Extraordinary FundamentalsTMDX+4.27%
The Motley FoolSun, 08 Mar 2026 09:22:00 GMTTransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026?TMDX+4.27%
Investors Business DailyThu, 05 Mar 2026 18:57:18 GMTMedical Stock Nears Buy Point Amid Liver Transplant Demand SurgeTMDX+4.27%
The Motley FoolSat, 28 Feb 2026 17:30:00 GMTGot $5,000? TransMedics Could Be a High‑Tech Organ Transplant MoonshotTMDX+4.27%
Zacks Investment ResearchWed, 25 Feb 2026 17:51:09 GMTTMDX Stock Rises as Q4 Earnings & Revenues Beat EstimatesTMDX+4.27%
Seeking AlphaWed, 25 Feb 2026 07:07:51 GMTTransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call TranscriptTMDX+4.27%
Zacks Investment ResearchWed, 25 Feb 2026 02:00:59 GMTTransMedics (TMDX) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesTMDX+4.27%
Zacks Investment ResearchWed, 25 Feb 2026 01:31:07 GMTTransMedics (TMDX) Beats Q4 Earnings and Revenue EstimatesTMDX+4.27%
Zacks Investment ResearchMon, 23 Feb 2026 15:16:19 GMTAhead of TransMedics (TMDX) Q4 Earnings: Get Ready With Wall Street Estimates for Key MetricsTMDX+4.27%
Zacks Investment ResearchMon, 16 Feb 2026 16:55:25 GMTTMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart TrialTMDX+4.27%
Seeking AlphaTue, 03 Feb 2026 12:15:01 GMTTransMedics: Italian NOP Program Reinforces Huge International OpportunityTMDX+4.27%
Zacks Investment ResearchWed, 14 Jan 2026 16:50:20 GMTReasons to Retain TransMedics Stock in Your Portfolio for NowTMDX+4.27%
